Next-Generation Dermal Delivery

50–95% of the drug in most patches never reaches your skin. We fixed that.

Explore the Technology
Investor Information

Up to 95% 

Payload Utilisation

72h

Tunable Release

2

Patent Families

3

Products in US Market
Three medical professionals, two women and one man, in white coats and glasses, examining a tablet device together in a clinical setting.
A gloved hand handling a pipette in a laboratory, with test tubes and a rack of samples on the table.
A close-up view of a network of interconnected, glowing blue fibers or filaments against a dark background, with a scale indicating a 500 nanometer marker.
ISO 9001 SGS Certification

ISO 9001 Certified

SGS Certified • North Ryde, Sydney

WHO WE ARE

Rethinking how patches work — from the fibre up.

EncapSolutions is a Sydney-based deep-tech company that rethought how patches work — from the fibre up. We developed SkinSync® — a patented dissolving nanofibre delivery platform that releases up to 95% of its active payload to the skin, over up to 72 hours. Standard patches waste 50–95% of what's inside them. We set out to fix that, and we did.

Founded in 2022, our team of scientists and entrepreneurs has taken SkinSync® from laboratory concept to U.S. retail shelves — backed by two international patent families, validated manufacturing at industrial scale, and early commercial traction across 20 U.S. stores and direct-to-consumer e-commerce.

  • ISO 14644–1 Class 7 Cleanroom Facility
  • ISO 9001 Quality Management System (SGS)
  • Electrospinning at industrial scale
  • Environmentally Responsible practices
Learn More
A researcher adjusting the settings on a microscope in a laboratory setting, with focus on the microscope's lenses and part of a person's hand.
Close-up of a soap bubble surface with a blue tint, showing intricate thin film patterns and reflections.
A person wearing black gloves is placing a clear glass container into a piece of laboratory equipment.
A person's arm with a medical bandage or adhesive bandage on it, being prepared for a blood draw or injection.

WHAT WE DO

We design dermal patches that actually deliver.

SkinSync® is our patented nanofibre technology platform. When applied to moist skin, the fibres dissolve, releasing active ingredients over 72 hours — achieving up to 95% payload utilisation compared to 5–50% in conventional patches.

Our first products apply SkinSync® to plant-based support & recovery — validating the platform commercially in the U.S. while building toward white-label, licensing, and pharma collaboration opportunities.

The technology works across molecules and indications. The platform is protected by two international patent families. Manufacturing is industrialised. And we're just getting started.

Learn More

WHY SKINSYNC®

Built to outperform conventional patches

  • Two international patent families
  • Industrial-scale manufacturing
  • U.S. retail and e-commerce

Efficient Delivery

Up to 95% payload utilisation vs. 5–50% in standard patches.

Sustained Release

Tunable release window from 12 to 72 hours.

Platform Technology

Works across molecules and indications — pain relief, and beyond.

PARTNERSHIP OPPORTUNITIES

Ready to explore partnership
or investment?

Connect with the EncapSolutions team about licensing, private-label manufacturing, or pharma collaboration.

Contact Us